Skip to main content
Liaoning Cheng Da Co.,Ltd. logo

Liaoning Cheng Da Co.,Ltd. — Investor Relations & Filings

Ticker · 600739 ISIN · CNE000000LY3 LEI · 300300ZCCWKNUJRL8D79 Shanghai Stock Exchange Financial and insurance activities
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2022-12-26 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600739

About Liaoning Cheng Da Co.,Ltd.

https://en.chengda.com.cn/

Liaoning Cheng Da Co., Ltd. is a diversified conglomerate operating across several strategic sectors, including biopharmaceuticals, financial services, energy development, and international trade. The company is a prominent player in the biopharmaceutical field through its specialized subsidiaries, focusing on the research, development, and production of human vaccines, most notably its market-leading purified Vero cell rabies vaccine. In the energy sector, it engages in the extraction and processing of oil shale. Its financial services division involves significant investments in securities firms and insurance companies. Additionally, the company maintains a robust international trade business, dealing in commodities such as textiles and chemicals. Liaoning Cheng Da focuses on integrating industrial operations with financial capital to drive growth across its various business units.

Recent filings

Filing Released Lang Actions
辽宁成大股份有限公司第十届董事会第十五次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the company's board of directors regarding decisions made at a specific board meeting. It includes voting results on various business proposals and references other announcements for details. There is no detailed financial data, audit information, or full report content. The document is about board decisions and meeting resolutions, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2022-12-26 Chinese
辽宁成大股份有限公司独立董事关于第十届董事会第十五次（临时）会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on specific agenda items discussed at the 15th (extraordinary) meeting of the 10th board of directors of Liaoning Chengda Co., Ltd. It references compliance with company law, securities law, and stock exchange listing rules, and provides independent opinions on the company's proposed derivative business activities for 2023. The document is a formal statement from independent directors regarding board meeting matters, not a full financial report, earnings release, or regulatory filing. It does not contain financial statements or detailed financial data. This type of document fits best under Board/Management Information (MANG), as it relates to board meeting matters and independent directors' opinions on company business proposals.
2022-12-26 Chinese
辽宁成大股份有限公司关于公司2023年度开展商品衍生品业务的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the board of directors of 辽宁成大股份有限公司 regarding the company's plan to conduct commodity derivatives business in 2023. It details the business scope, risk management, accounting policies, and includes the independent directors' opinion. The document is a formal announcement about a new business activity and risk management related to commodity derivatives, not a financial report, earnings release, or regulatory filing. It does not contain financial statements or quarterly/yearly results. It is not a report publication announcement since it contains substantive content about the business plan and risk controls. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about business operations and risk management.
2022-12-26 Chinese
辽宁成大股份有限公司第十届监事会第九次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Liaoning Chengda Co., Ltd. regarding the company's response to a regulatory corrective action imposed by the Dalian Securities Regulatory Bureau. It includes details about the meeting, the corrective report, and the voting results. The document does not contain financial statements or detailed financial data, nor is it a full report like an Annual Report or Interim Report. It is an official announcement related to regulatory compliance and corrective measures. Given its nature as a formal announcement of a board meeting decision and regulatory response, it fits best under Regulatory Filings (RNS). The document length is short (845 characters), and it is not merely announcing the publication of a report but providing the resolution details itself.
2022-12-26 Chinese
辽宁成大股份有限公司关于大连证监局对公司采取责令改正措施的整改报告
Audit Report / Information Classification · 95% confidence The document is a detailed整改报告 (rectification report) issued by 辽宁成大股份有限公司 in response to a regulatory corrective order from the Dalian Securities Regulatory Bureau. It addresses multiple compliance and internal control issues, including information disclosure, insider information management, financial accounting, and internal controls. The document includes specific corrective measures, responsibilities, and completion status. It also contains an attachment with detailed financial data related to non-operating fund occupation and related party transactions for the year 2020. The document is not a full annual or interim financial report but a regulatory compliance and audit-related report responding to a regulatory order. It is not a simple announcement or certification but a substantive report on audit findings and corrective actions. Therefore, it fits best under the category of Audit Report / Information (AR). FY 2020
2022-12-26 Chinese
辽宁成大股份有限公司关于2022年度第一期超短期融资券到期兑付公告
Capital/Financing Update Classification · 100% confidence The document is a short announcement regarding the maturity and repayment of a short-term financing bond issued by the company. It mentions the issuance details, maturity date, and confirmation of repayment. There are no financial statements or detailed financial analysis present. The document is under 5,000 characters and serves as an update on financing activity, specifically about bond maturity and repayment. Therefore, it fits the category of Capital/Financing Update (CAP).
2022-12-21 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.